The MedTech Investment Challenge
MedTech investing is high-stakes. Regulatory delays, technical setbacks, and market timing can make or break a portfolio company, but most investors don't see problems until it's too late.
Traditional quarterly reporting is too slow. By the time you learn about a regulatory setback or a missed milestone, months of runway have been burned.
You need real-time visibility into your portfolio companies' development progress, regulatory status, and financial health.
Black Box Investments
Portfolio companies report quarterly (at best), leaving you blind to day-to-day progress and emerging risks.
Manual, Inconsistent Reporting
Every company sends different formats, making portfolio-wide analysis nearly impossible.
Late-Stage Surprises
Regulatory rejections, clinical setbacks, and cash crunches surface too late for course correction.
Investor Workspace Capabilities
Purpose-built tools for MedTech portfolio monitoring and due diligence
Real-Time Portfolio Visibility
See every portfolio company's status at a glance, regulatory milestones, development progress, and financial health updated in real-time.
KPI Watchtower
Monitor standardized KPIs across all investments. Track cash runway, milestone velocity, and regulatory readiness with automated dashboards.
Due Diligence Rooms
Secure virtual data rooms for pre-investment analysis. Review documentation, regulatory history, and risk assessments before committing capital.
Milestone Monitoring
Track critical milestones across your portfolio, 510(k) submissions, CE marking, clinical trials, and commercial launches.
Risk Assessment
Automated risk scoring based on regulatory progress, team execution, and market factors. Identify at-risk investments early.
Secure Data Rooms
Encrypted, audit-ready data rooms for sensitive investment documentation. Full access control and activity logging.
Why Investors Choose Xyreg
Better Deal Flow
Access promising MedTech startups already building on Xyreg, pre-vetted for regulatory best practices.
Investment Transparency
Real-time visibility into portfolio company progress. No more waiting for quarterly updates.
Portfolio Company Support
Help your investments succeed by sponsoring their access to Xyreg's full workspace capabilities.
Sponsorship Packages
Support your portfolio companies while gaining oversight capabilities
Starter
5 startups
€1,999
/month
- 5 Helix Workspace licenses for portfolio companies
- 5 KPI Watchtower slots
- 2 Due Diligence rooms
Growth
10 startups
€3,499
/month
- 10 Helix Workspace licenses for portfolio companies
- 10 KPI Watchtower slots
- 5 Due Diligence rooms
Portfolio
25+ startups
Custom
/month
- 25+ Helix Workspace licenses
- Unlimited KPI slots
- Unlimited DD rooms
The Xyreg Investor Advantage
Real-Time Investment Insights
Stop waiting for quarterly updates. See portfolio company progress as it happens, milestones hit, documents approved, risks emerging.
Standardized Reporting
All portfolio companies report in the same format, making cross-portfolio analysis and comparison straightforward.
De-Risk Your Investments
Early warning on regulatory delays, technical setbacks, or execution problems. Intervene before small issues become deal-breakers.
Increase Portfolio Value
Companies building on Xyreg demonstrate regulatory maturity that drives higher valuations and smoother exits.
"In MedTech, what you don't see can kill a deal. Xyreg gives investors the visibility they need to protect and grow their investments."